OKL-1014

N/A

Report date: 2025/01/26 17:31:37
NME

Base Information

Drug NameOKL-1014
Drug Alias NameOKL-LS1 program (Okklo Life Sciences)cyclodextrin based therapeutics (Okklo Life Sciences)OKL-1014
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNiemann-Pick Disease, Type C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOkklo Life Sciences BV
China Registration ClassN/A

Develop Information

Active CompaniesOkklo Life Sciences BV
Inactive CompaniesN/A
Active IndicationsNiemann-Pick Disease, Type C
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A